Please Wait.....
Report
North America Veterinary Pain Management Market - Industry Trends and Forecast to 2034
Market Report I 2023-09-01 I 150 Pages I Data Bridge Market Research
North America veterinary pain management market is expected to reach USD 1,256,306.51 thousand by 2030 from USD 728,148.69 thousand in 2022 growing at a CAGR of 7.2% in the forecast period of 2023 to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022 and the forecast period is 2023 to 2030.
Market Segmentation
North America Veterinary Pain Management Market, By Product Type (Analgesics, Corticosteroids, and Alpha 2 Agonists), Drug Type (Branded and Generic), Mode of Purchase (Prescription Based and OTC), Animal Type (Companion Animal and Production Animal), Pain Source (Chronic Pain, Acute Pain, Post-Operative Pain, and Dental Pain), Dosage (Solid, Liquid, and Semi-Solid), Route of Administration (Parenteral, Oral, and Topical), End User (Veterinary Hospitals, Veterinary Clinics, Pet Shops, Animal Farms, Academic & Research Institutes, and Others), Country (U.S., Canada, and Mexico) - Industry Trends and Forecast to 2030
Overview of North America Veterinary Pain Management Market Dynamics
Driver
- Rising incidences of pet diseases
Restraint
- High costs of pet care
Opportunity
- Technological advancements for pain management
Market Players
Some of the major market players operating in the North America veterinary pain management market are:
- Dechra Pharmaceuticals PLC
- Virbac
- Norbrook
- Durvet Animal Health Products
- Bimeda, Inc.
- Inovet ( A subsidiary of Orion Group)
- Chanelle Pharma
- Vetoquinol
- Elanco
- Merck & Co., Inc.
- Zoetis Services LLC
- Ceva Animal Health, LLC
TABLE OF CONTENTS
1 INTRODUCTION 17
1.1 OBJECTIVES OF THE STUDY 17
1.2 MARKET DEFINITION 17
1.3 OVERVIEW OF THE NORTH AMERICA VETERINARY PAIN MANAGEMENT MARKET 17
1.4 CURRENCY AND PRICING 19
1.5 LIMITATIONS 19
1.6 MARKETS COVERED 20
2 MARKET SEGMENTATION 23
2.1 MARKETS COVERED 23
2.2 GEOGRAPHICAL SCOPE 24
2.3 YEARS CONSIDERED FOR THE STUDY 25
2.4 DBMR TRIPOD DATA VALIDATION MODEL 26
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 29
2.6 MULTIVARIATE MODELLING 30
2.7 MARKET END USER COVERAGE GRID 30
2.8 PRODUCT LIFELINE CURVE 31
2.9 DBMR MARKET POSITION GRID 32
2.10 VENDOR SHARE ANALYSIS 33
2.11 SECONDARY SOURCES 34
2.12 ASSUMPTIONS 34
3 EXECUTIVE SUMMARY 35
4 PREMIUM INSIGHTS 38
4.1 PESTEL ANALYSIS 39
4.2 PORTER'S FIVE FORCES 40
4.3 BRAND REVENUE ANALYSIS 41
5 MARKET OVERVIEW 42
5.1 DRIVERS 44
5.1.1 INCREASING PET OWNERSHIP 44
5.1.2 ADVANCEMENTS IN VETERINARY MEDICINE 44
5.1.3 GROWING INCIDENCES OF PET DISEASES 45
5.1.4 INCREASED GOVERNMENT PROJECTS TO ENHANCE ANIMAL CARE 45
5.2 RESTRAINTS 46
5.2.1 INCREASING PET CARE COSTS 46
5.2.2 STRICT REGULATORY GUIDELINES 46?
5.3 OPPORTUNITIES 47
5.3.1 RISING R&D ACTIVITIES AND PRODUCT APPROVAL FOR VETERINARY PAIN MANAGEMENT 47
5.3.2 RISING POPULARITY OF NON- CONVENTIONAL TREATMENT APPROACHES 48
5.3.3 TECHNOLOGICAL ADVANCEMENTS 48
5.4 CHALLENGES 49
5.4.1 LIMITED AVAILABILITY OF VETERINARIANS 49
5.4.2 RESISTANCE TO MEDICATIONS 49
6 NORTH AMERICA VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE 50
6.1 OVERVIEW 51
6.2 ANALGESICS 52
6.2.1 ANTI- INFLAMMATORY (NSAIDS) 52
6.2.1.1 CARPROFEN 53
6.2.1.2 MELOXICAM 53
6.2.1.3 PHENYLBUTAZONE 53
6.2.1.4 ACETAMINOPHEN 53
6.2.1.5 FIROCOXIB 53
6.2.1.6 DERACOXIB 53
6.2.1.7 OTHERS 54
6.2.2 OPIOIDS 54
6.2.2.1 MU AGONISTS 54
6.2.2.1.1 METHADONE 55
6.2.2.1.2 MEPERIDINE 55
6.2.2.1.3 MORPHINE 55
6.2.2.1.4 OXYMORPHONE 55
6.2.2.1.5 OTHERS 55
6.2.2.2 PARTIAL MU AGONIST 55
6.2.2.2.1 BUPRENORPHINE 55
6.2.2.2.2 OTHERS 56
6.2.2.3 KAPPA AGONIST MU ANTAGONIST 56
6.2.2.3.1 BUTORPHANOL 56
6.2.2.3.2 OTHERS 56
6.3 CORTICOSTEROIDS 57
6.3.1 DEXAMETHASONE 57
6.3.2 PREDNISOLONE 57
6.3.3 PREDNISONE 57
6.3.4 OTHERS 58
6.4 ALPHA 2 AGONISTS 58?
7 NORTH AMERICA VETERINARY PAIN MANAGEMENT MARKET, BY DRUG TYPE 59
7.1 OVERVIEW 60
7.2 BRANDED 61
7.3 GENERIC 61
8 NORTH AMERICA VETERINARY PAIN MANAGEMENT MARKET, BY MODE OF PURCHASE 62
8.1 OVERVIEW 63
8.2 PRESCRIPTION BASED 64
8.3 OTC 64
9 NORTH AMERICA VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE 65
9.1 OVERVIEW 66
9.2 COMPANION ANIMAL 67
9.2.1 CANINE 68
9.2.2 EQUINE 68
9.2.3 FELINE 68
9.2.4 OTHERS 68
9.3 PRODUCTION ANIMAL 68
9.3.1 CATTLE 69
9.3.2 SWINE 69
9.3.3 POULTRY 69
9.3.4 FISH 69
9.3.5 OTHERS 69
10 NORTH AMERICA VETERINARY PAIN MANAGEMENT MARKET, BY PAIN SOURCE 70
10.1 OVERVIEW 71
10.2 CHRONIC PAIN 72
10.3 ACUTE PAIN 73
10.4 POST OPERATIVE PAIN 73
10.5 DENTAL PAIN 74
11 NORTH AMERICA VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE 75
11.1 OVERVIEW 76
11.2 SOLID 77
11.2.1 TABLET 77
11.2.2 POWDER 78
11.2.3 OTHERS 78?
11.3 LIQUID 78
11.3.1 SOLUTION 78
11.3.2 SYRUP 79
11.3.3 SUSPENSION 79
11.3.4 OTHERS 79
11.4 SEMI SOLID 79
11.4.1 GEL 80
11.4.2 CREAM 80
11.4.3 OTHERS 80
12 NORTH AMERICA VETERINARY PAIN MANAGEMENT MARKET, BY ROUTE OF ADMINISTRATION 81
12.1 OVERVIEW 82
12.2 PARENTERAL 83
12.3 ORAL 84
12.4 TOPICAL 84
13 NORTH AMERICA VETERINARY PAIN MANAGEMENT MARKET, BY END USER 85
13.1 OVERVIEW 86
13.2 VETERINARY HOSPITALS 87
13.3 VETERINARY CLINICS 88
13.4 PET SHOPS 88
13.5 ANIMAL FARMS 89
13.6 ACADEMIC & RESEARCH INSTITUTES 89
13.7 OTHERS 90
14 NORTH AMERICA VETERINARY PAIN MANAGEMENT MARKET, BY GEOGRAPHY 91
14.1 NORTH AMERICA 92
14.1.1 U.S. 100
14.1.2 CANADA 107
14.1.3 MEXICO 115
15 NORTH AMERICA VETERINARY PAIN MANAGEMENT MARKET, COMPANY LANDSCAPE 122
15.1 COMPANY SHARE ANALYSIS: NORTH AMERICA 122
16 SWOT ANALYSIS 123?
17 COMPANY PROFILE 124
17.1 ZOETIS SERVICES LLC 124
17.1.1 COMPANY SNAPSHOT 124
17.1.2 COMPANY SHARE ANALYSIS 124
17.1.3 PRODUCT PORTFOLIO 125
17.1.4 RECENT DEVELOPMENTS 125
17.2 ELANCO 126
17.2.1 COMPANY SNAPSHOT 126
17.2.2 REVENUE ANALYSIS 126
17.2.3 COMPANY SHARE ANALYSIS 127
17.2.4 PRODUCT PORTFOLIO 127
17.2.5 RECENT DEVELOPMENT 127
17.3 MERCK & CO., INC. 128
17.3.1 COMPANY SNAPSHOT 128
17.3.2 REVENUE ANALYSIS 128
17.3.3 COMPANY SHARE ANALYSIS 129
17.3.4 PRODUCT PORTFOLIO 129
17.3.5 RECENT DEVELOPMENT 129
17.4 BOEHRINGER INGELHEIM INTERNATIONAL GMBH 130
17.4.1 COMPANY SNAPSHOT 130
17.4.2 COMPANY SHARE ANALYSIS 130
17.4.3 PRODUCT PORTFOLIO 131
17.4.4 RECENT DEVELOPMENT 131
17.5 VETOQUINOL 132
17.5.1 COMPANY SNAPSHOT 132
17.5.2 REVENUE ANALYSIS 132
17.5.3 COMPANY SHARE ANALYSIS 133
17.5.4 PRODUCT PORTFOLIO 133
17.5.5 RECENT DEVELOPMENTS 133
17.6 BIMEDA, INC. 135
17.6.1 COMPANY SNAPSHOT 135
17.6.2 PRODUCT PORTFOLIO 135
17.6.3 RECENT DEVELOPMENT 135
17.7 CEVA ANIMAL HEALTH, LLC 136
17.7.1 COMPANY SNAPSHOT 136
17.7.2 PRODUCT PORTFOLIO 136
17.7.3 RECENT DEVELOPMENT 136?
17.8 CHANELLE PHARMA 137
17.8.1 COMPANY SNAPSHOT 137
17.8.2 PRODUCT PORTFOLIO 137
17.8.3 RECENT DEVELOPMENT 137
17.9 DECHRA PHARMACEUTICALS PLC 138
17.9.1 COMPANY SNAPSHOT 138
17.9.2 REVENUE ANALYSIS 138
17.9.3 PRODUCT PORTFOLIO 139
17.9.4 RECENT DEVELOPMENTS 139
17.10 DURVET ANIMAL HEALTH PRODUCTS 140
17.10.1 COMPANY SNAPSHOT 140
17.10.2 PRODUCT PORTFOLIO 140
17.10.3 RECENT DEVELOPMENT 140
17.11 INOVET (A SUBSIDIARY OF ORION GROUP) 141
17.11.1 COMPANY SNAPSHOT 141
17.11.2 PRODUCT PORTFOLIO 141
17.11.3 RECENT DEVELOPMENTS 141
17.12 NORBROOK 143
17.12.1 COMPANY SNAPSHOT 143
17.12.2 PRODUCT PORTFOLIO 143
17.12.3 RECENT DEVELOPMENT 143
17.13 VIRBAC 144
17.13.1 COMPANY SNAPSHOT 144
17.13.2 REVENUE ANALYSIS 144
17.13.3 PRODUCT PORTFOLIO 145
17.13.4 RECENT DEVELOPMENT 145
18 QUESTIONNAIRE 146
19 RELATED REPORTS 150
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security